-
Jun 30, 2025, 08:12 AM
by
Laverock Therapeutics closes additional seed funding round, bringing total raised to more than £20m, and announces key data
Full story
-
Jun 27, 2025, 08:17 AM
by
Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for the American Academy of Pediatrics’ (AAP) updated guidance recommending whole genome and whole exome sequencing as first-tier tests. Baylor Genetics has long recognized the value of these tests, and offers a comprehensive, structured framework to help pediatricians promptly identify potential genetic causes in children presenting with global developmental delay (GDD) or intellectual disability (ID). This milestone empowers pediatricians, supported by genetics professionals, with access to earlier and more comprehensive insights that guide clinical decisions for patients and their families, marking a critical step toward faster diagnoses and improved outcomes.
Full story
-
Jun 26, 2025, 07:59 AM
by
The project aims at translational mechanistic modeling of antibodies to predict human pharmacokinetics and target occupancy in cerebrospinal fluid
Full story
-
Jun 26, 2025, 07:59 AM
by
Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.
Full story
-
Jun 26, 2025, 07:59 AM
by
ISM3412 was designed with the support of Chemistry42, Insilico’s proprietary generative chemistry engine, for the treatment of locally advanced and metastatic solid tumors.
The Phase I study of ISM3412 is currently recruiting in multiple sites across the United States and China, aiming to evaluate the safety, tolerability, PK/PD profiles and preliminary efficacy in patients.
Full story
-
Jun 26, 2025, 01:00 AM
by
User Not Found
Bio-IT World | The UK's National Health Service is pioneering a new approach to precision medicine through pharmacogenomic testing that could transform how doctors prescribe medications and significantly reduce healthcare costs. Early results from the NHS PROGRESS trial suggest that genetic testing can guide prescribing decisions for nearly all patients, with one in four participants having their prescriptions adjusted for safer or more effective treatment.
Full story
-
Jun 25, 2025, 08:26 AM
by
Full story
-
Jun 25, 2025, 08:26 AM
by
Full story
-
Jun 25, 2025, 08:26 AM
by
Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.
Full story
-
Jun 25, 2025, 08:26 AM
by
AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.
Full story
-
Jun 25, 2025, 08:26 AM
by
Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes
Full story
-
Jun 25, 2025, 08:26 AM
by
To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.
Full story
-
Jun 25, 2025, 01:00 AM
by
User Not Found
Bio-IT World | ITM plans to use their financing to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide, which treats gastroenteropancreatic neuroendocrine tumors; GRIN and Angelini Pharma will develop and expand commercial rights outside of North America for GRIN's investigational drug radiprodil, which treats rare genetic epilepsies and neurodevelopmental disorders; and more.
Full story
-
Jun 24, 2025, 08:19 AM
by
Vaxess Technologies, Inc., a biotech company developing a novel microarray patch technology to transform home delivery of therapies, is presenting new preclinical data at the 2025 American Diabetes Association (ADA) Scientific Sessions in Chicago.
Full story
-
Jun 24, 2025, 01:00 AM
by
User Not Found
Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.
Full story
-
Jun 23, 2025, 08:09 AM
by
Full story
-
Jun 23, 2025, 08:09 AM
by
Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.
Full story
-
Jun 23, 2025, 08:09 AM
by
As supply chain instability and international backorders continue to affect the life sciences and diagnostics sectors, Zymo Research is stepping in with scalable, U.S.-based alternatives. Our latest announcement spotlights our domestic manufacturing capabilities and our role as a long-standing OEM and development partner, helping research and clinical labs maintain continuity without compromise. We believe this is especially relevant to your readers, many of whom are actively seeking reliable domestic partners. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/supply-chain-challenges
Full story
-
Jun 23, 2025, 08:09 AM
by
Bill Kerr of Avalon Healthcare Solutions Named EY Entrepreneur Of The Year® 2025 Florida Award Winner - Leader in Diagnostic Intelligence & Insights Earns Top Recognition for Transformative Work
Full story
-
Jun 23, 2025, 08:07 AM
by
Lindus Health Named a Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category
Full story